Matches in Nanopublications for { ?s ?p "Importantly, GRD expression resulted in the activation of both the Rb and p53 pathways (Figure 3D), and the same cell cycle inhibitors were upregulated in human cells treated with NF1- specific shRNA constructs (Figure 3F), with the exception of p16, which was only activated in NF1KD- and not GRD-expressing cells." ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- _4 value "Importantly, GRD expression resulted in the activation of both the Rb and p53 pathways (Figure 3D), and the same cell cycle inhibitors were upregulated in human cells treated with NF1- specific shRNA constructs (Figure 3F), with the exception of p16, which was only activated in NF1KD- and not GRD-expressing cells." provenance.
- _4 value "Importantly, GRD expression resulted in the activation of both the Rb and p53 pathways (Figure 3D), and the same cell cycle inhibitors were upregulated in human cells treated with NF1- specific shRNA constructs (Figure 3F), with the exception of p16, which was only activated in NF1KD- and not GRD-expressing cells." provenance.
- _4 value "Importantly, GRD expression resulted in the activation of both the Rb and p53 pathways (Figure 3D), and the same cell cycle inhibitors were upregulated in human cells treated with NF1- specific shRNA constructs (Figure 3F), with the exception of p16, which was only activated in NF1KD- and not GRD-expressing cells." provenance.
- _4 value "Importantly, GRD expression resulted in the activation of both the Rb and p53 pathways (Figure 3D), and the same cell cycle inhibitors were upregulated in human cells treated with NF1- specific shRNA constructs (Figure 3F), with the exception of p16, which was only activated in NF1KD- and not GRD-expressing cells." provenance.